Oct 28, 2021 - Dr. Mary Kate Anderson ('20) recently published an article entitled Brexucabtagene Autoleucel: A Novel Chimeric Antigen Receptor t-cell Therapy for the Treatment of Mantle Cell Lymphoma. Annals of Pharmacotherapy.
Dr. Mary Kate Anderson Publishes Article
Filed Under: Alumni News